Breakthrough Therapy Designation for RYBREVANT FASPRO™ in Advanced Head and Neck Cancer Johnson & Johnson’s RYBREVANT FASPRO™ has received Breakthrough Therapy Designation from the FDA for the treatment of advanced head and neck cancer, promising new hope for patients.

Breakthrough Therapy Designation for RYBREVANT FASPRO™ in Advanced Head and Neck Cancer #USA #Johnson_&_Johnson #Raritan #FDA_Breakthrough #RYBREVANT_FASPRO

CND Life Sciences Achieves FDA Breakthrough Device Designation for Syn-One Test® CND Life Sciences has received the FDA's Breakthrough Device Designation for its Syn-One Test, aiding in the diagnosis of synucleinopathies in patients.

CND Life Sciences Achieves FDA Breakthrough Device Designation for Syn-One Test® #USA #Scottsdale #CND_Life_Sciences #Syn-One_Test #FDA_Breakthrough

PatenSee Achieves FDA Breakthrough Designation for Revolutionary Hemodialysis Monitoring Technology PatenSee has been granted FDA's Breakthrough Device Designation for its non-contact vascular access management technology, promising enhanced kidney care.

PatenSee Achieves FDA Breakthrough Designation for Revolutionary Hemodialysis Monitoring Technology #United_States #Detroit #FDA_Breakthrough #PatenSee #Hemodialysis

Restore Medical Ltd. Raises $23 Million for Innovative Heart Failure Device Restore Medical Ltd. has successfully raised $23 million in financing to propel its groundbreaking transcatheter therapy for heart failure, aiming to enhance patient outcomes worldwide.

Restore Medical Ltd. Raises $23 Million for Innovative Heart Failure Device #Israel #Heart_Failure #Or_Yehuda #FDA_Breakthrough #Restore_Medical

SonoClear AS Achieves FDA Breakthrough Designation for Innovative SonoClear® System SonoClear AS has received FDA breakthrough designation for its SonoClear® System, enhancing imaging during brain tumor surgery. This breakthrough aims to improve surgical outcomes.

SonoClear AS Achieves FDA Breakthrough Designation for Innovative SonoClear® System #Norway #Oslo #brain_tumors #FDA_Breakthrough #SonoClear

CytoSorbents Reports Financial Performance for Q1 2025 and Business Innovations CytoSorbents Corporation has reported its Q1 2025 financial results, highlighting revenue changes and strategic advancements in their business operations.

CytoSorbents Reports Financial Performance for Q1 2025 and Business Innovations #United_States #Princeton #FDA_Breakthrough #CytoSorbents #DrugSorb-ATR

Phantom Neuro's FDA Breakthrough Recognition Enhances Neurotech Innovation for Mobility Solutions Phantom Neuro achieves FDA Breakthrough Device and TAP Designations, reinforcing its position in neurotechnology for intuitive mobility solutions.

Phantom Neuro's FDA Breakthrough Recognition Enhances Neurotech Innovation for Mobility Solutions #USA #Austin #Neurotechnology #FDA_Breakthrough #Phantom_Neuro

OrthoPreserve Revolutionizes Knee Pain Treatment with Breakthrough Implant Technology OrthoPreserve's innovative meniscus implant, Defender, gains FDA Breakthrough Device Designation, marking a significant advancement in knee pain management.

OrthoPreserve Revolutionizes Knee Pain Treatment with Breakthrough Implant Technology #USA #Richmond #OrthoPreserve #Defender_Implant #FDA_Breakthrough